Luiz Gustavo Feijó Dubois

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Campus de Xerém

Unidade:

Setor de Pessoal/Xerém

Departamento:

Docentes/Xerém

ORCID:

não disponível no Lattes


Formação:
  • New York University

    | Pós-Doutorado | 2018 - 2018
  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2014 - 2015
  • Universidade Federal do Rio de Janeiro

    Ciências Morfológicas | Doutorado | 2009 - 2013
  • Universidade Federal do Rio de Janeiro

    Biomedicina | Graduação | 2004 - 2007
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(90.00% artigos com DOI)

Titulo DOI Ano
Case report: Regression of Glioblastoma after flavivirus infection 10.3389/fmed.2023.1192070 2023
Obstacles to Glioblastoma Treatment Two Decades after Temozolomide 10.3390/cancers14133203 2022
p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors 10.1007/s13402-017-0361-5 2018
GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling 10.1007/s12035-018-1150-5 2018
Glioblastoma Therapy in the Age of Molecular Medicine 10.1016/j.trecan.2018.11.002 2018
A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma 2017
Bisacodyl and its cytotoxic activity on human glioblastoma stem-like cells. Implication of inositol 1,4,5-triphosphate receptor dependent calcium signaling 10.1016/j.bbamcr.2017.01.010 2017
Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition 10.1007/s13402-017-0320-1 2017
The Expression of Connexins and SOX2 Reflects the Plasticity of Glioma Stem-Like Cells 10.1016/j.tranon.2017.04.005 2017
Glioblastoma entities express subtle differences in molecular composition and response to treatment 10.3892/or.2017.5799 2017
Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness 10.1007/s00401-017-1783-x 2017
The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKC -dependent inhibition of the AKT pathway 10.15252/emmm.201505421 2016
The availability of the embryonic TGF-β protein Nodal is dynamically regulated during glioblastoma multiforme tumorigenesis 10.1186/s12935-016-0324-3 2016
Connective-Tissue Growth Factor (CTGF/CCN2) Induces Astrogenesis and Fibronectin Expression of Embryonic Neural Cells In Vitro 10.1371/journal.pone.0133689 2015
The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model 10.1186/1471-2407-14-923 2014
Gliomas and the vascular fragility of the blood brain barrier 10.3389/fncel.2014.00418 2014
Sirtuin-2 Activity is Required for Glioma Stem Cell Proliferation Arrest but not Necrosis Induced by Resveratrol 10.1007/s12015-013-9465-0 2013
Differential Proteomic Analysis of Human Glioblastoma and Neural Stem Cells Reveals HDGF as a Novel Angiogenic Secreted Factor 10.1002/stem.1062 2012
Glioblastoma cells: a heterogeneous and fatal tumor interacting with the parenchyma 2011
Tenascin-C in the extracellular matrix promotes the selection of highly proliferative and tubulogenesis-defective endothelial cells 10.1016/j.yexcr.2011.06.006 2011
Eventos:
Nenhum evento cadastrado
Publicações:
Minha Rede: